Navigation Links
Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program
Date:10/14/2009

SAN DIEGO, Oct. 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform. The study evaluated patients treated with the Excellarate product candidate (GAM501, which is a combination of Ad5PDGF-B and 2.6% collagen) or 2.6% collagen alone (matrix), compared to patients who received only the protocol-specified standard of care without any applied Ad5PDGF-B or collagen matrix. The Company will hold a webcast and conference call to discuss the clinical results of the Excellarate Matrix Phase 2b clinical study today, October 14, 2009, at 5:00 p.m. ET (access information is provided below).

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

The Excellarate product candidate and its components Ad5PDGF-B and collagen matrix appear to be both safe and well tolerated by patients. The Phase 2b study was abbreviated and enrollment ended early after key efficacy measures among blinded groups were observed at rates substantially higher than those expected for patients receiving only standard of care. Consistent with those observations, the unblinded data set showed a substantial (55%) relative improvement in achieving complete wound closure by 12 weeks (the key efficacy measure for a Phase 3 product registration program) among patients treated with a single dose of Excellarate as compared to patients receiving standard of care. Nearly half of patients (48%) receiving a one-time Excellarate treatment had complete wound closure
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
2. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
3. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
4. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
5. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
6. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
7. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
8. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
9. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
10. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
11. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Edward Avalos, USDA Under Secretary for Marketing and ... the California Department of Food and Agriculture, have been ... Conference: The Future of Local Food, conference organizers announced ... known experts intensifies an already strong line-up of sustainable ... to speak at the June 11-13 event. ...
(Date:4/21/2015)... Respected academic institution selects Visage 7 ... Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of ... seven-year contract with University of Florida Health — a ... deal furthers the penetration of Visage 7 ... of the North American enterprise imaging market. Visage ...
(Date:4/21/2015)... Wojo Nutrition announces ... at its healthiest, will carry Wojo Nutrition's lines of ... Wojo Nutrition, they’ve launched a revolution in the vitamin ... to meet their multifaceted goals. Their line of single ... beverage, has been specially formulated to be as unique ...
(Date:4/21/2015)... Now in its fifteenth year, the TU-Automotive Detroit ... 3,000 senior attendees from across the automotive, technology ... on June 3 and 4. This year leading ... are set to deliver headline and keynote presentations ... as connectivity paves the way towards smart mobility ...
(Date:4/21/2015)... Carinsuranceshoppingsource.com has released a new blog post ... plans . , Comprehensive auto insurance is a ... The coverage limit can also be high and the ... a car against fire damage, vandalism, theft and from ... longer difficult and it can help drivers find the ...
Breaking Medicine News(10 mins):Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 2Health News:USDA Under Secretary, former CA Agriculture Director to Address 2nd Annual “GrowRIVERSIDE” Conference in June 3Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:Wojo Nutrition Announces their Lines of Single Serving Liquid Vitamins will be Available for Purchase online at Abesmarket.com Beginning in May 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 3Health News:Comprehensive Auto Insurance Is An Important But Complex Policy 2
... used to repair the breastbone after it is intentionally broken ... technique uses a state-of-the-art adhesive that rapidly bonds to bone ... heal the breastbone in hours instead of weeks after open-heart ... and get back to full physical activities in days instead ...
... ... ... In lockstep with the nation,s focus on healthcare, Oprah Winfrey has for the first ... tourism." Introduced on Oprah.com Monday, November 9th, the segment presents medical tourism as a ...
... ... topic of Alzheimer,s prevention. , ... Naples, FL (PRWEB) November 12, 2009 -- Integrative neurologist, Dr. David ... on the topic of Alzheimer,s disease prevention. The conference will be held in Monaco, ...
... ... Senior Quality Lifestyles Corporation (SQLC), a Texas-based nonprofit developer of senior living ... Stayton at Museum Way. A 501(c)3 nonprofit life care retirement community, The ... located at Stayton Street and Museum Way in the Fort Worth Cultural ...
... ULURU Inc. (NYSE Alternext: ULU), ... portfolio of wound management and oral care products, today announced ... of its common stock at a price per share of ... resulting in gross proceeds of approximately $1.5 million. , Investors ...
... (LSE: SHP, Nasdaq: SHPGY ), the global ... examining emotional lability from Phase 3 study data with ... significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by ... Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 ...
Cached Medicine News:Health News:Surgeon 'gluing' the breastbone together after open-heart surgery 2Health News:Medical Tourism Hits Oprah.com 2Health News: Integrative Neurologist Breaks Ground in Alzheimer's Prevention 2Health News:Senior Quality Lifestyles Corporation Announces Completion of $164,855,000 in Financing for The Stayton at Museum Way 2Health News:Senior Quality Lifestyles Corporation Announces Completion of $164,855,000 in Financing for The Stayton at Museum Way 3Health News:ULURU Inc. to Raise $1.5 Million in Registered Direct Offering 2Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 2Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 3Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 4Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 5Health News:Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII 6
(Date:4/21/2015)... 2015 The global dermatology diagnostic devices market ... from 2014 to 2019. North America ... shares in the global dermatology diagnostic devices market. The ... mainly attributed to a wide range of factors, such ... dermatologists, and technological advancements made in the field of ...
(Date:4/21/2015)... A groundbreaking new, minimally invasive outpatient treatment ... procedure is now readily available to the estimated 1 ... 25-55 who suffer from this condition. ... world,s leading practitioner of this safe, effective, Federal Drug ... two new Los Angeles -area medical ...
(Date:4/21/2015)... YORK , April 21, 2015 This ... US$ Thousands by the following Types: Equipment for Therapeutic ... analyzed by the following Applications: Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and ... US, Canada , Japan ... Asia-Pacific , and Rest of World. Annual estimates ...
Breaking Medicine Technology:Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 2Dermatology Diagnostic Devices Market by Product, by End-User - Global Forecast to 2019 3New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 2New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 3New Minimally Invasive Treatment for Uterine Fibroids Offers Life-Changing Relief, Without a Hysterectomy, to 1 Million Southern California Women 4World Apheresis Equipment Industry 2World Apheresis Equipment Industry 3World Apheresis Equipment Industry 4World Apheresis Equipment Industry 5World Apheresis Equipment Industry 6World Apheresis Equipment Industry 7World Apheresis Equipment Industry 8World Apheresis Equipment Industry 9World Apheresis Equipment Industry 10World Apheresis Equipment Industry 11World Apheresis Equipment Industry 12World Apheresis Equipment Industry 13World Apheresis Equipment Industry 14World Apheresis Equipment Industry 15World Apheresis Equipment Industry 16World Apheresis Equipment Industry 17World Apheresis Equipment Industry 18World Apheresis Equipment Industry 19World Apheresis Equipment Industry 20World Apheresis Equipment Industry 21
Part of the Octopus System which includes both the Starfish & Octopus3. The Starfish Heart Positioner simplifies cardiac positioning and minimizes the associated hemodynamic deterioration when compa...
... tight spaces easily? Introducing the Guidant ... latest innovation in mechanical tissue stabilization.,The ... low-profile feet, innovative FlexLink technology, and ... maneuverability, and access to target vessels.,Include ...
... The AB-180 iVAD*, implantable ... a surgically implantable device ... The inflow and outflow ... the VAD and anatomically ...
Datascope presents a unique new product for post-hemostasis puncture site management. Safeguard is the first product ever to combine a built-in inflatable bulb and a sterile dressing- providing adjus...
Medicine Products: